» Articles » PMID: 35587456

Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years - United States, 2019

Overview
Date 2022 May 19
PMID 35587456
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer disease,* the most common cause of dementia, affects an estimated 6.5 million persons aged ≥65 years in the United States (1). A growing body of evidence has identified potential modifiable risk factors for Alzheimer disease and related dementias (ADRD) (1-3). In 2021, the National Plan to Address Alzheimer's Disease (National Plan) introduced a new goal to "accelerate action to promote healthy aging and reduce risk factors for Alzheimer's disease and related dementias" to help delay onset or slow the progression of ADRD (3). To assess the status of eight potential modifiable risk factors (i.e., high blood pressure, not meeting the aerobic physical activity guideline, obesity, diabetes, depression, current cigarette smoking, hearing loss, and binge drinking), investigators analyzed data from the cognitive decline module that was administered to adults aged ≥45 years in 31 states and the District of Columbia (DC) in the 2019 Behavioral Risk Factor Surveillance System (BRFSS) survey. Among the risk factors, prevalence was highest for high blood pressure (49.9%) and lowest for binge drinking (10.3%) and varied by selected demographic characteristics. Adults with subjective cognitive decline (SCD), an early indicator of possible future ADRD (4), were more likely to report four or more risk factors than were those without SCD (34.3% versus 13.1%). Prevalence of SCD was 11.3% overall and increased from 3.9% among adults with no risk factors to 25.0% among those with four or more risk factors. Implementing evidence-based strategies to address modifiable risk factors can help achieve the National Plan's new goal to reduce risk for ADRD while promoting health aging.*.

Citing Articles

Development and validation of a frailty risk model for patients with mild cognitive impairment.

Cui Y, Xu Z, Cui Z, Guo Y, Wu P, Zhou X Sci Rep. 2025; 15(1):3814.

PMID: 39885318 PMC: 11782627. DOI: 10.1038/s41598-025-88275-y.


Multidimensional relationships between sensory perception and cognitive aging.

Kannan L, Lelo de Larrea-Mancera E, Maniglia M, Vodyanyk M, Gallun F, Jaeggi S Front Aging Neurosci. 2025; 16:1484494.

PMID: 39759398 PMC: 11695427. DOI: 10.3389/fnagi.2024.1484494.


Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer's Disease, a Potential Therapeutic Target.

Puranik N, Song M Molecules. 2024; 29(23).

PMID: 39683904 PMC: 11643865. DOI: 10.3390/molecules29235744.


Chasing shadows: Investigating X chromosome mediation in late-onset Alzheimer's disease.

Armon C, Cannon-Albright L, Allen-Brady K, Wolfson S Adv Neurol (Singap). 2024; 3(2).

PMID: 39634155 PMC: 11616353. DOI: 10.36922/an.3122.


The Effect of Levels of Leisure-Time Physical Activity on Cognitive Functions Among Older Adults with Mild Cognitive Impairment: A Longitudinal Analysis.

Kim J, Lee J, Kim J, Woo B Gerontol Geriatr Med. 2024; 10:23337214241291705.

PMID: 39502310 PMC: 11536382. DOI: 10.1177/23337214241291705.


References
1.
Olivari B, Jeffers E, Tang K, McGuire L . Improving Brain Health for Populations Disproportionately Affected by Alzheimer's Disease and Related Dementias. Clin Gerontol. 2022; 46(2):128-132. PMC: 10291276. DOI: 10.1080/07317115.2022.2043977. View

2.
Mayeda E, Glymour M, Quesenberry C, Whitmer R . Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement. 2016; 12(3):216-24. PMC: 4969071. DOI: 10.1016/j.jalz.2015.12.007. View

3.
Taylor C, Bouldin E, McGuire L . Subjective Cognitive Decline Among Adults Aged ≥45 Years - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018; 67(27):753-757. PMC: 6047468. DOI: 10.15585/mmwr.mm6727a1. View

4.
. 2022 Alzheimer's disease facts and figures. Alzheimers Dement. 2022; 18(4):700-789. DOI: 10.1002/alz.12638. View

5.
Matthews K, Xu W, Gaglioti A, Holt J, Croft J, Mack D . Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged ≥65 years. Alzheimers Dement. 2018; 15(1):17-24. PMC: 6333531. DOI: 10.1016/j.jalz.2018.06.3063. View